Exagen (XGN) Total Liabilities (2018 - 2026)

Exagen has reported Total Liabilities for 9 years, with the latest figure at $37.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 10.72% year-over-year to $37.5 million; the trailing twelve-month figure through Mar 2026 stood at $37.5 million (up 10.72% YoY), and the FY2025 full-year result was $40.6 million, up 15.43% from the prior year.
• Total Liabilities for Q1 2026 stood at $37.5 million, down from $40.6 million in the prior quarter.
• The five-year high for Total Liabilities was $45.9 million in Q1 2022, with the low at $30.7 million in Q3 2024.
• Historically, Total Liabilities has averaged $38.0 million across 5 years, with a median of $37.5 million in 2026.
• Annual changes were most pronounced in 2024 — Total Liabilities dropped 28.82% — and 2025, when it soared 45.38%.
• Exagen's Total Liabilities stood at $43.8 million in 2022, then dropped by 21.73% to $34.2 million in 2023, then grew by 2.62% to $35.1 million in 2024, then grew by 15.43% to $40.6 million in 2025, then retreated by 7.51% to $37.5 million in 2026.
• The last three Total Liabilities figures came in at $37.5 million (Q1 2026), $40.6 million (Q4 2025), and $44.7 million (Q3 2025), per Business Quant data.